Study Looks at Survival in Metastatic NSCLC Treated With Immunotherapy

WEDNESDAY, Dec. 13, 2023 -- For patients with metastatic non-small cell lung cancer (NSCLC) receiving immunotherapy, outcomes are similar across racial and ethnic groups, but ECOG performance status (PS) is associated with survival, according to a...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news